Angiopoietin 1 Receptor Market Report

Global and Region Angiopoietin 1 Receptor Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：215
  • REPORT CODE：GMM961576
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Angiopoietin 1 Receptor market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Angiopoietin 1 Receptormarket, defines the market attractiveness level of Angiopoietin 1 Receptor market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Angiopoietin 1 Receptor industry, describes the types of Angiopoietin 1 Receptor market, the applications of major players and the market size, and deeply analyzes the current situation of the global Angiopoietin 1 Receptor market and the development prospects and opportunities of Angiopoietin 1 Receptor industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Angiopoietin 1 Receptor market in Chapter 13.

    By Player:

    • Pfizer Inc

    • Exelixis, Inc

    • Aerpio Therapeutics, Inc

    • Sanofi

    • Teva Pharmaceutical Industries Ltd

    • PharmAbcine, Inc

    • Deciphera Pharmaceuticals, LLC

    • Eddingpharm

    By Type:

    • MAN-01

    • PMC-001

    • AP-185

    • ARP-1536

    • Others

    By End-User:

    • Bladder Cancer

    • Neuroendocrine Tumors

    • Ovarian Cancer

    • Ureter Cancer

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Angiopoietin 1 Receptor Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Angiopoietin 1 Receptor Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Angiopoietin 1 Receptor Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Angiopoietin 1 Receptor Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Angiopoietin 1 Receptor Market Analysis and Outlook to 2022

    • 7.1 Global Angiopoietin 1 Receptor Consumption (2017-2022)

    • 7.2 United States Angiopoietin 1 Receptor Consumption (2017-2022)

    • 7.3 Europe Angiopoietin 1 Receptor Consumption (2017-2022)

    • 7.4 China Angiopoietin 1 Receptor Consumption (2017-2022)

    • 7.5 Japan Angiopoietin 1 Receptor Consumption (2017-2022)

    • 7.6 India Angiopoietin 1 Receptor Consumption (2017-2022)

    • 7.7 South Korea Angiopoietin 1 Receptor Consumption (2017-2022)

    8 Region and Country-wise Angiopoietin 1 Receptor Market Analysis and Outlook to 2028

    • 8.1 Global Angiopoietin 1 Receptor Consumption Forecast (2022-2028)

    • 8.2 United States Angiopoietin 1 Receptor Consumption Forecast (2022-2028)

    • 8.3 Europe Angiopoietin 1 Receptor Consumption Forecast (2022-2028)

    • 8.4 China Angiopoietin 1 Receptor Consumption Forecast (2022-2028)

    • 8.5 Japan Angiopoietin 1 Receptor Consumption Forecast (2022-2028)

    • 8.6 India Angiopoietin 1 Receptor Consumption Forecast (2022-2028)

    • 8.7 South Korea Angiopoietin 1 Receptor Consumption Forecast (2022-2028)

    9 Global Angiopoietin 1 Receptor Market Outlook by Types and Applications to 2022

    • 9.1 Global Angiopoietin 1 Receptor Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global MAN-01 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global PMC-001 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global AP-185 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global ARP-1536 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Angiopoietin 1 Receptor Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Bladder Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Neuroendocrine Tumors Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Ovarian Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Ureter Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Angiopoietin 1 Receptor Market Outlook by Types and Applications to 2028

    • 10.1 Global Angiopoietin 1 Receptor Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global MAN-01 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global PMC-001 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global AP-185 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global ARP-1536 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Angiopoietin 1 Receptor Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Neuroendocrine Tumors Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Ureter Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Angiopoietin 1 Receptor Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Angiopoietin 1 Receptor Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Angiopoietin 1 Receptor Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Angiopoietin 1 Receptor Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Angiopoietin 1 Receptor Market Competitive Analysis

    • 14.1 Pfizer Inc

      • 14.1.1 Pfizer Inc Company Details

      • 14.1.2 Pfizer Inc Angiopoietin 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Pfizer Inc Angiopoietin 1 Receptor Product and Service

    • 14.2 Exelixis, Inc

      • 14.2.1 Exelixis, Inc Company Details

      • 14.2.2 Exelixis, Inc Angiopoietin 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Exelixis, Inc Angiopoietin 1 Receptor Product and Service

    • 14.3 Aerpio Therapeutics, Inc

      • 14.3.1 Aerpio Therapeutics, Inc Company Details

      • 14.3.2 Aerpio Therapeutics, Inc Angiopoietin 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Aerpio Therapeutics, Inc Angiopoietin 1 Receptor Product and Service

    • 14.4 Sanofi

      • 14.4.1 Sanofi Company Details

      • 14.4.2 Sanofi Angiopoietin 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sanofi Angiopoietin 1 Receptor Product and Service

    • 14.5 Teva Pharmaceutical Industries Ltd

      • 14.5.1 Teva Pharmaceutical Industries Ltd Company Details

      • 14.5.2 Teva Pharmaceutical Industries Ltd Angiopoietin 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Teva Pharmaceutical Industries Ltd Angiopoietin 1 Receptor Product and Service

    • 14.6 PharmAbcine, Inc

      • 14.6.1 PharmAbcine, Inc Company Details

      • 14.6.2 PharmAbcine, Inc Angiopoietin 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 PharmAbcine, Inc Angiopoietin 1 Receptor Product and Service

    • 14.7 Deciphera Pharmaceuticals, LLC

      • 14.7.1 Deciphera Pharmaceuticals, LLC Company Details

      • 14.7.2 Deciphera Pharmaceuticals, LLC Angiopoietin 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Deciphera Pharmaceuticals, LLC Angiopoietin 1 Receptor Product and Service

    • 14.8 Eddingpharm

      • 14.8.1 Eddingpharm Company Details

      • 14.8.2 Eddingpharm Angiopoietin 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Eddingpharm Angiopoietin 1 Receptor Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Angiopoietin 1 Receptor

    • Figure Angiopoietin 1 Receptor Picture

    • Table Global Angiopoietin 1 Receptor Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Angiopoietin 1 Receptor Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Angiopoietin 1 Receptor Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Angiopoietin 1 Receptor Consumption by Country (2017-2022)

    • Figure United States Angiopoietin 1 Receptor Consumption and Growth Rate (2017-2022)

    • Table Europe Angiopoietin 1 Receptor Consumption and Growth Rate (2017-2022)

    • Figure China Angiopoietin 1 Receptor Consumption and Growth Rate (2017-2022)

    • Figure Japan Angiopoietin 1 Receptor Consumption and Growth Rate (2017-2022)

    • Figure India Angiopoietin 1 Receptor Consumption and Growth Rate (2017-2022)

    • Figure South Korea Angiopoietin 1 Receptor Consumption and Growth Rate (2017-2022)

    • Figure Global Angiopoietin 1 Receptor Consumption Forecast by Country (2022-2028)

    • Figure United States Angiopoietin 1 Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Angiopoietin 1 Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Angiopoietin 1 Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Angiopoietin 1 Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Angiopoietin 1 Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Angiopoietin 1 Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global MAN-01 Consumption and Growth Rate (2017-2022)

    • Figure Global PMC-001 Consumption and Growth Rate (2017-2022)

    • Figure Global AP-185 Consumption and Growth Rate (2017-2022)

    • Figure Global ARP-1536 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Bladder Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Neuroendocrine Tumors Consumption and Growth Rate (2017-2022)

    • Figure Global Ovarian Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Ureter Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global MAN-01 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global PMC-001 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global AP-185 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ARP-1536 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neuroendocrine Tumors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ureter Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Angiopoietin 1 Receptor Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Angiopoietin 1 Receptor Export by Region (Top 5 Countries) (2017-2028)

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Angiopoietin 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Angiopoietin 1 Receptor Product and Service

    • Table Exelixis, Inc (Foundation Year, Company Profile and etc.)

    • Table Exelixis, Inc Angiopoietin 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Exelixis, Inc Angiopoietin 1 Receptor Product and Service

    • Table Aerpio Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Aerpio Therapeutics, Inc Angiopoietin 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aerpio Therapeutics, Inc Angiopoietin 1 Receptor Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Angiopoietin 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Angiopoietin 1 Receptor Product and Service

    • Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Ltd Angiopoietin 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Ltd Angiopoietin 1 Receptor Product and Service

    • Table PharmAbcine, Inc (Foundation Year, Company Profile and etc.)

    • Table PharmAbcine, Inc Angiopoietin 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table PharmAbcine, Inc Angiopoietin 1 Receptor Product and Service

    • Table Deciphera Pharmaceuticals, LLC (Foundation Year, Company Profile and etc.)

    • Table Deciphera Pharmaceuticals, LLC Angiopoietin 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Deciphera Pharmaceuticals, LLC Angiopoietin 1 Receptor Product and Service

    • Table Eddingpharm (Foundation Year, Company Profile and etc.)

    • Table Eddingpharm Angiopoietin 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eddingpharm Angiopoietin 1 Receptor Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US